What's breaking now, across thousands of outlets.
(MedPage Today) -- New multiple sclerosis (MS) patients treated with B-cell-depleting drugs or high-efficacy therapies had lower relapse rates and fewer brain lesions than those treated with oral drugs, but at 2 years, disability outcomes were...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.
New research from the University of Oklahoma identifies a protein in liver cells that appears to help drive the development of liver cancer associated with obesity-related fatty liver disease.
Obesity caused by disrupted stress-hormone rhythms is metabolically very different from obesity caused by a high-fat diet, according to a new preclinical study by Weill Cornell Medicine investigators.
The CDC said it has received a rise in reports of human rabies exposure cases this summer, prompting an alert to healthcare providers.
The death of a Canberra woman is the first in the ACT to be linked to a synthetic opioid which is estimated to be at least 100 times stronger than heroin, a coroner has found.
(MedPage Today) -- Adding the BCL2 inhibitor venetoclax (Venclexta) to chemoimmunotherapy led to worse outcomes and excess mortality in patients with newly diagnosed double-hit lymphoma, phase II…
